Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | sodium channel, voltage-gated, type IX, alpha subunit | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | STE family protein kinase | 0.0219 | 0.0269 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.6493 | 1 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0185 | 0.0216 | 0.0216 |
Schistosoma mansoni | protein kinase | 0.0219 | 0.0269 | 0.0054 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0185 | 0.0216 | 0.0216 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0185 | 0.0216 | 0.803 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0185 | 0.0216 | 0.5 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.6493 | 1 | 1 |
Giardia lamblia | Kinase, STE STE20 | 0.0219 | 0.0269 | 1 |
Echinococcus multilocularis | dual specificity mitogen activated protein | 0.0219 | 0.0269 | 0.0269 |
Loa Loa (eye worm) | STE/STE7/MEK1 protein kinase | 0.0219 | 0.0269 | 0.0054 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0185 | 0.0216 | 0.0216 |
Trypanosoma cruzi | mitogen-activated protein kinase kinase 5 | 0.0219 | 0.0269 | 1 |
Trypanosoma brucei | mitogen-activated protein kinase kinase 5 | 0.0219 | 0.0269 | 1 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.6493 | 1 | 1 |
Leishmania major | mitogen-activated protein kinase kinase 5, putative;with=GeneDB:LmxM36.0860 | 0.0219 | 0.0269 | 1 |
Trichomonas vaginalis | STE family protein kinase | 0.0219 | 0.0269 | 1 |
Brugia malayi | Dual specificity mitogen-activated protein kinase kinase mek-2 | 0.0219 | 0.0269 | 0.0054 |
Echinococcus granulosus | dual specificity mitogen activated protein | 0.0219 | 0.0269 | 0.0269 |
Trichomonas vaginalis | STE family protein kinase | 0.0219 | 0.0269 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0185 | 0.0216 | 0.0216 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0185 | 0.0216 | 0.803 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.6493 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2780 nM | BindingDB_Patents: FLIPR Assay. Recombinant Nav1.7 Cell Line: In vitro assays were performed in a recombinant cell line expressing cDNA encoding the alpha subunit (Nav1.7, SCN9a, PN1, NE) of human Nav1.7 (Accession No. NM__002977). The cell line was provided by investigators at Yale University (Cummins et al, J. Neurosci. 18(23): 9607-9619 (1998)). For dominant selection of the Nav1.7-expressing clones, the expression plasmid co-expressed the neomycin resistance gene. The cell line was constructed in the human embryonic kidney cell line, HEK293, under the influence of the CMV major late promoter, and stable clones were selected using limiting dilution cloning and antibiotic selection using the neomycin analogue, G418. Recombinant beta and gamma subunits were not introduced into this cell line. Additional cell lines expressing recombinant Nav1.7 cloned from other species can also be used, alone or in combination with various beta subunits, gamma subunits or chaperones.Non-Recombinant Cell Lines Expressing Native Nav1. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.